Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Khaled A Elsayad

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Pharmaceuticals (Basel, Switzerland)|May 27, 2026
Interpretable QSAR, External PubChem Validation, and Coordination-Aware Docking Enable Tiered Prioritization of Carbonic Anhydrase I InhibitorsAlaa M Elsayad, Khaled A Elsayad
Pharmaceuticals (Basel, Switzerland)|May 4, 2026
Interpretable QSAR and Complementary Docking for PARP1 Inhibitor Prioritization: Reliability Stratification and Near-Domain ScreeningAlaa M Elsayad, Khaled A Elsayad
Scientific Reports|April 20, 2026
Interpretable QSAR models for acute oral toxicity via tuned XGBoost and hybrid data sampling techniquesAlaa M Elsayad, Medien Zeghid, Hassan Yousif Ahmed, et al.
International Journal of Environmental Research and Public Health|December 16, 2020
Classification of Biodegradable Substances Using Balanced Random Trees and Boosted C5.0 Decision TreesAlaa M Elsayad, Ahmed M Nassef, Mujahed Al-Dhaifallah, et al.
Bioorganic Chemistry|May 7, 2024
Sulfonamides as anticancer agents: A brief review on sulfonamide derivatives as inhibitors of various proteins overexpressed in cancerKhaled A Elsayad, Ghada F Elmasry, Sally T Mahmoud, et al.
Bioorganic Chemistry|March 14, 2025
Development of novel amino-benzenesulfonamide derivatives and their analogues as carbonic anhydrase inhibitors: Design, synthesis, anticancer activity assessment, and pharmacokinetic studies using UPLC-MS/MSKhaled A Elsayad, Ghada F Elmasry, Sally T Mahmoud, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Pharmaceuticals (Basel, Switzerland)|May 27, 2026
Interpretable QSAR, External PubChem Validation, and Coordination-Aware Docking Enable Tiered Prioritization of Carbonic Anhydrase I InhibitorsAlaa M Elsayad, Khaled A Elsayad
Pharmaceuticals (Basel, Switzerland)|May 4, 2026
Interpretable QSAR and Complementary Docking for PARP1 Inhibitor Prioritization: Reliability Stratification and Near-Domain ScreeningAlaa M Elsayad, Khaled A Elsayad
Scientific Reports|April 20, 2026
Interpretable QSAR models for acute oral toxicity via tuned XGBoost and hybrid data sampling techniquesAlaa M Elsayad, Medien Zeghid, Hassan Yousif Ahmed, et al.
International Journal of Environmental Research and Public Health|December 16, 2020
Classification of Biodegradable Substances Using Balanced Random Trees and Boosted C5.0 Decision TreesAlaa M Elsayad, Ahmed M Nassef, Mujahed Al-Dhaifallah, et al.
Bioorganic Chemistry|May 7, 2024
Sulfonamides as anticancer agents: A brief review on sulfonamide derivatives as inhibitors of various proteins overexpressed in cancerKhaled A Elsayad, Ghada F Elmasry, Sally T Mahmoud, et al.
Bioorganic Chemistry|March 14, 2025
Development of novel amino-benzenesulfonamide derivatives and their analogues as carbonic anhydrase inhibitors: Design, synthesis, anticancer activity assessment, and pharmacokinetic studies using UPLC-MS/MSKhaled A Elsayad, Ghada F Elmasry, Sally T Mahmoud, et al.
Pageof 1